Access cutting-edge epilepsy treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access epilepsy specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epilepsy treatment provided free
To generate preliminary safety and effectiveness data for brain-responsive neurostimulation of thalamocortical networks as an adjunctive therapy in reducing the frequency of generalized seizures in individuals 12 years of age or older with Lennox Gastaut Syndrome (LGS) who are refractory to antiseizure medications. The intent is to determine the feasibility and the optimal design of a subsequent pivotal study in order to expand the indication for use for the RNS System as a treatment for patien
Sponsor: NeuroPace
Check if you qualify for this epilepsy clinical trial in New York, NY
If you're searching for epilepsy treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.